Major milestone as VeraForm®used in the treatment of more than 1000 patients! Aiming to improve identification and treatment of tumor beds. Patient satisfaction & clinical adoption of VeraForm is truly exciting; proud to be involved with such dedicated clinicians.
#ASBRS, #bcsm
We're excited to welcome @JoshDeFonzo to the Concur Biophotonics Advisory Board.
Josh is currently Co-Founder & CEO of @Mendaerainc and previously helped lead Auris Health through its acquisition by @JNJNews before serving as President of Robotics & Digital Solutions at J&J.
His extensive experience in building and scaling healthcare innovation will be invaluable as we continue advancing Real-Time ESSAI® tissue sensing technology.
Welcome aboard, Josh!
Great presentation at AAMD today. Dominic Rafie discussing how VeraForm® improves patient alignment and treatment accuracy in breast-conserving radiotherapy. #ASTRO#BCSM#ASBrS
https://t.co/yLXoMlaOYx
The way boundaries were always meant to be shown.
You don't drop dashes on a map to tell someone where you camped. You draw the whole line. The full shape.
That's VeraForm® — a continuous 3D radiopaque marker. The whole tumor bed, not a scattering of points.
Concur Biophotonics has enrolled the first prostate patients in its ongoing SENSE clinical study at @providence Mission Hospital and @OCUrologyAssoc.
The study now expands beyond current Robot Assisted Bronchoscopies (RAB) and Trans-Thoracic needle, liver & kidney biopsies into MRI Fusion prostate biopsy procedures; all leveraging Concur’s Real-Time ESSAI® tissue classification platform to enable real-time tissue sensing and differentiation during interventional procedures.
The prostate study is led by Dr. Daniel Su, urologic oncology surgeon and Chief Medical Officer at @OCUrologyAssoc.
A meaningful step forward in expanding real-time optical tissue classification across interventional procedures in multiple specialties.
#ProstateCancer #Urology
That's a wrap on #ASBrS2026 in Seattle! Thank you to every surgeon who stopped by the @ASBrS meeting to see VeraForm, the only continuous, 3D, radiopaque tissue marker for breast-conserving surgery, oncoplastics & partial breast radiation.
#CareBeyondClips. Staying 'TrueToForm'.
"I assume that's the tumor bed. It's kind of hard to be sure."
That's a radiation oncologist describing what it's like to contour with clips.
Clips show points. They don't define volume.
VeraForm does.
36,000+ patients and counting.
https://t.co/DMLv5SgJC2
Who else is at #ASBrS2026 in Seattle?
Drop a 👋 — we want to say hi.
Videra Surgical, Booth 112. We didn't come for brochures. We came for one real conversation about better tumor bed contouring.
Wouldn't it be reassuring to know there's a 3D marker that defines the entire breast tumor bed — and you can't feel it?
Here's how the cavity is contoured for precise radiation planning.
VeraForm by Videra.
🔗 in bio
BioZorb® removed from market. VeraForm remains best option:
•Patient-friendly Non-palpable; metal free
•Safe >23,000 pts; no adverse events
•Cost-effective 1/3 cost of BZ; only 1 SKU; No hardware
•Data: patient radiation reduction; Superior to clips
https://t.co/t5SX9PB31k
Press: @ASTRO_org meeting: Study from @InovaHealth: Avg >80% reduction in radiation (PTV) for BCS pts w. VeraForm & APBI w breath-hold. Independent, powerful data coinciding with Breast Cancer Awareness month @ASBrS@SCWilley#BCSM@breastcancerorg
https://t.co/cHjI9xFI4n
Accepted @aapmHQ study. VeraForm w proprietary imaging signature auto detect by @mimsoftware ProtégéAI+ software. Help for RT planning post BCS. MIM auto contour w VeraForm demos automatic workflow on par with manual RT plan. Steps to standardization.
https://t.co/bNYVVB3lu3
Excited to announce >20,000 patients have been treated with the VeraForm® marker! Huge milestone. We're at @ASBRS meeting next week in Orlando. Visit us at booth 433 & hear about clinical impact of VeraForm in BCS and how it rises beyond surgical clips.
#BCSM#Carebeyondclips
Join us at @SocSurgOnc meeting this week where we'll be engaging surgeons on the benefits of the #VeraForm tumor bed marker for breast conserving surgery. Thousands of patients have received VeraForm. Hear why it is #beyondclips for RT planning and treatment.
#bcsm#lumpectomy
Outstanding article. Rad Onc Dr. Brian Lawenda (@IOEssentials) discusses adoption of VeraForm marker and positive impact on breast cancer patients and workflow. Superior to clips, especially with oncoplastics. #bcsm@providence @GenesisCareUS
https://t.co/ngVzkwCOfT
Excited to share today's press release; Peer-reviewed study published in American Journal of Clinical Oncology. Details superiority VeraForm® marker vs clips, delineating tumor bed for targeting RT following BCS. @ASTRO_org@ASBrS#bcsm
https://t.co/9ZMcrfnZ3P
Excited to be in Boston this week @ASBrS. Stop by (booth 1010) and hear how thousand of patients are benefitting from the VeraForm® marker in BCS & why so many surgeons have switched to VeraForm to better mark the cavity vs. clips or other approaches.
#BCSM
The official inauguration of the Fatima bint Mubarak Center represents a new era of cancer care in Abu Dhabi, the UAE and the entire region. Named in honor of HH Sheikha Fatima bint Mubarak— the Mother of the Nation, the center brings world-class complex care closer to home...
Videra will be at this weekend's @LARadiological (LARS) meeting in Pasadena. Come see us at Table 18 & learn about the latest clinical advancements with the VeraForm® marker in BCS
# VeraForm # Lumpectomy